Business Services Industry
Understand Alfacell Corp's Strategic Position by Accessing Detailed Independent Intelligence on Its Product Pipeline
Business Wire, Jan 23, 2008
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c80383) has announced the addition of "Alfacell Corp.-Detailed Product Pipeline" to their offering.
Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information, deals and alliances and recent news on the company including key milestones.
Scope of the reports
Each Life Science Analytics' Pipeline Report provides the user with real detail on a company's pipeline.
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company's product pipeline and disease hub classification.
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company's deals and alliances and recent corporate news including key milestones.
Key benefits
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
Keep track of your competitors and partners by better understanding their product pipeline.
Monitor a company's research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.
Contents: Financial Reports Company Details Price Info (Table/Graph) Business Overview Share Price Information Stock Performance History(Last 3 Yrs) (Graph) Price and Volume Dividends (Table/Graph) Market Related Data (Table/Graph) Valuation (Table/Graph) Revenues (Table/Graph) Earnings and Earnings Per Share Margin Ratios (Table/Graph) Return Ratios (Table/Graph) Financial Strength (Table/Graph) Growth Ratios Days Sales Outstanding (End of Period Receivables) Days Outstanding Inventory (End of Period Inventory) Cash and Short Term Investments per Share Quarterly (Graph) Total Common Shares Outstanding Quarterly (Graph) Quarterly Book Value Per Share vs Share Price (Graph)
For more information visit http://www.researchandmarkets.com/reports/c80383
Source: Life Science Analytics
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Content provided in partnership with
Most Recent Business Articles
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- LIFO vs. FIFO: a return to the basics
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Using object-oriented analysis and design over traditional structured analysis and design
- Design a commission plan that drives sales - Sales Commissions
